Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
13.08
-0.16 (-1.21%)
At close: Feb 6, 2026, 4:00 PM EST
13.24
+0.16 (1.22%)
After-hours: Feb 6, 2026, 7:50 PM EST
Beta Bionics Market Cap
Beta Bionics has a market cap or net worth of $575.84 million as of February 6, 2026.
Market Cap
575.84M
Enterprise Value
354.84M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.08
Market Cap Chart
Since the IPO on January 30, 2025, Beta Bionics's market cap has decreased from $695.12M to $575.84M, a decrease of -17.16%. That is a compound annual growth rate of -16.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 575.84M | -57.07% |
| Dec 31, 2025 | 1.34B | 92.98% |
| Jan 30, 2025 | 695.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avanos Medical | 677.25M |
| SI-BONE | 676.69M |
| Tactile Systems Technology | 623.39M |
| Varex Imaging | 586.87M |
| Cytek Biosciences | 571.56M |
| Bioventus | 570.97M |
| Pacific Biosciences of California | 549.47M |
| Perspective Therapeutics | 536.54M |